Steatotic Liver Disease
Conditions
Interventions
None listed
Sponsors
Ogaki Municipal Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1,Patients with SLD in which hepatitis C, hereditary, drug-related, or other associations have been ruled out. However, patients with SLD associated with hepatitis B, autoimmune hepatitis, and primary biliary cirrhosis shall be eligible. 2,Patients with SLD associated with hepatitis B, autoimmune hepatitis, or primary biliary cirrhosis are eligible. Patients who are currently under observation and have not had a quantitative MRI after an interval of at least one year are also included, as are patients who have obtained a new consent form and had a quantitative MRI after an interval of at least one year. 3,Patients without concurrent hepatocellular carcinoma at the time of the first quantitative MRI. However, patients who subsequently developed hepatocellular carcinoma will be included if more than one year has passed since the first quantitative MRI and the interval between the second (or more than one) quantitative MRI measurement and the first quantitative MRI measurement is more than one year. 4,Patients whose participation is deemed appropriate by the principal investigator or subinvestigator.
Exclusion criteria
Exclusion criteria: 1,Patients with claustrophobia 2,Patients with magnetic materials or tattoos on the body 3,Patients with a pacemaker 4,Patients who are judged by the principal investigator or subinvestigator to be unsuitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver stiffness (liver fibrosis), the factor most strongly related to prognosis, was used as the objective variable to analyze how the degree and change of hepatic steatois and other factors are related to the progression of liver fibrosis. | — |
Countries
Japan
Contacts
Public ContactTakashi Kumada
Gifu Kyoritsu University Faculty of Nursing
Outcome results
None listed